Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November-2021 Volume 24 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2021 Volume 24 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

PPM1A as a key target of the application of Jiawei‑Maxing‑Shigan decoction for the attenuation of radiation‑induced epithelial‑mesenchymal transition in type II alveolar epithelial cells

  • Authors:
    • Jinhua Lu
    • Shengyou Lin
    • Zechen Lin
    • Xianlei Lin
    • Yuezhong Shen
    • Jingyang Su
  • View Affiliations / Copyright

    Affiliations: Oncology Department, Dingqiao Branch of GuangXing Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310007, P.R. China, Oncology Department, GuangXing Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310007, P.R. China, Graduate School, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310007, P.R. China
    Copyright: © Lu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 825
    |
    Published online on: September 24, 2021
       https://doi.org/10.3892/mmr.2021.12465
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Radiation‑induced lung tissue injury is an important reason for the limited application of radiotherapy on thoracic malignancies. Previously, we reported that administration of Jiawei‑Maxing‑Shigan decoction (JMSD) attenuated the radiation‑induced epithelial‑mesenchymal transition (EMT) in alveolar epithelial cells (AECs) via TGF‑β/Smad signaling. The present study aimed to examine the role of protein phosphatase Mg2+/Mn2+‑dependent 1A (PPM1A) in the anti‑EMT activity of JMSD on AECs. The components in the aqueous extract of JMSD were identified by high‑performance liquid chromatography coupled with electrospray mass spectrometry. Primary rat type II AECs were treated with radiation (60Co γ‑ray at 8 Gy) and JMSD‑medicated serum. PPM1A was overexpressed and knocked down in the AECs via lentivirus transduction and the effects of JMSD administration on the key proteins related to TGF‑β1/Smad signaling were measured by western blotting. It was found that radiation decreased the PPM1A expression in the AECs and JMSD‑medicated serum upregulated the PPM1A expressions in the radiation‑induced AECs. PPM1A overexpression increased the E‑cadherin level but decreased the phosphorylated (p‑)Smad2/3, vimentin and α‑smooth muscle actin (α‑SMA) levels in the AECs. By contrast, the PPM1A knockdown decreased the E‑cadherin level and increased the p‑Smad2/3, vimentin and α‑SMA levels in the AECs and these effects could be blocked by SB431542 (TGF‑β1/Smad signaling inhibitor). JMSD administration increased the E‑cadherin level and decreased the p‑Smad2/3, vimentin and α‑SMA levels in the AECs; however, these effects could be blocked by siPPM1A‑2. In conclusion, PPM1A is a key target of JMSD administration for the attenuation of the radiation‑induced EMT in primary type II AECs via the TGF‑β1/Smad pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Tian S, Zhang X, Jiang R, Pillai RN, Owonikoko TK, Steuer CE, Saba NF, Pakkala S, Patel PR, Belani CP, et al: Survival outcomes with thoracic radiotherapy in extensive-stage small-cell lung cancer: A propensity score-matched analysis of the national cancer database. Clin Lung Cancer. 20:484–493.e6. 2019. View Article : Google Scholar : PubMed/NCBI

2 

Rodrigues G and Movsas B: Future directions in palliative thoracic radiotherapy. Curr Opin Support Palliat Care. 6:91–96. 2012. View Article : Google Scholar : PubMed/NCBI

3 

Simone CB II: Thoracic radiation normal tissue injury. Semin Radiat Oncol. 27:370–377. 2017. View Article : Google Scholar : PubMed/NCBI

4 

Giuranno L, Ient J, De Ruysscher D and Vooijs MA: Radiation-Induced Lung Injury (RILI). Front Oncol. 9:8772019. View Article : Google Scholar : PubMed/NCBI

5 

Ota C, Ng-Blichfeldt JP, Korfei M, Alsafadi HN, Lehmann M, Skronska-Wasek W, M De Santis M, Guenther A, Wagner DE and Königshoff M: Dynamic expression of HOPX in alveolar epithelial cells reflects injury and repair during the progression of pulmonary fibrosis. Sci Rep. 8:129832018. View Article : Google Scholar : PubMed/NCBI

6 

Nagarajan D, Wang L, Zhao W and Han X: Trichostatin A inhibits radiation-induced epithelial-to-mesenchymal transition in the alveolar epithelial cells. Oncotarget. 8:101745–101759. 2017. View Article : Google Scholar : PubMed/NCBI

7 

Lu J, Zhong Y, Lin X, Lin Z, Chen Z, Wu X, Wang N and Lin S: Jiawei Maxing Shigan Decoction (JMSD) attenuates radiation-induced epithelial-mesenchymal transition of primary rat type II alveolar epithelial cells. Int J Clin Exp Med. 10:16292–16300. 2017.

8 

Yan-He LI: Clinical effect of Jiawei Maxingshigan decoction treatment for pediatric asthma. Laboratory Medicine & Clinic. 2013.

9 

Lin T and Geng R: To Observe the Curative Effect of Western Medicine in the Treatment Combined With Jiawei Maxingshigan Decoction in Treating Acute Attack of Chronic Bronchitis. China Continuing Medical Education. 2015.

10 

Li J: Clinical observation of Jiawei Maxing Shigan Decoction in complementary treatment of 48 cases of infantile mycoplasma pneumonia. J Pediatr Traditional Chin Med. 3:40–41. 2007.(In Chinese).

11 

Wang J, Li YQ, Zhang WP, Zhang T and Zhou X: The effects of Jiawei Maxing Shigan Decoction on radioactive lung injury Tianjin. J Traditional Chin Med. 28:377–378. 2011.

12 

Geng J, Fan J, Ouyang Q, Zhang X, Zhang X, Yu J, Xu Z, Li Q, Yao X, Liu X and Zheng J: Loss of PPM1A expression enhances invasion and the epithelial-to-mesenchymal transition in bladder cancer by activating the TGF-β/Smad signaling pathway. Oncotarget. 5:5700–5711. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Lammers T, Peschke P, Ehemann V, Debus J, Slobodin B, Lavi S and Huber P: Role of PP2Calpha in cell growth, in radio- and chemosensitivity, and in tumorigenicity. Mol Cancer. 6:642007. View Article : Google Scholar

14 

Mazumdar A, Tahaney WM, Reddy Bollu L, Poage G, Hill J, Zhang Y, Mills GB and Brown PH: The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression. NPJ Breast Cancer. 5:222019. View Article : Google Scholar : PubMed/NCBI

15 

Zhang JT, Wang P, Liu AF, Yang G, Yuan-Dong LI and Zhang C: Overview about preparation methods of serum containing Chinese medicine. China J Traditional Chin Med Pharm. 2015.

16 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

17 

Ghasemian M, Owlia S and Owlia MB: Review of anti-inflammatory herbal medicines. Adv Pharmacol Sci. 2016:91309792016.PubMed/NCBI

18 

Peng W, Qin R, Li X and Zhou H: Botany, phytochemistry, pharmacology, and potential application of Polygonum cuspidatum Sieb.et Zucc.: A review. J Ethnopharmacol. 148:729–745. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Zeng H, Wang Y, Gu Y, Wang J, Zhang H, Gao H, Jin Q and Zhao L: Polydatin attenuates reactive oxygen species-induced airway remodeling by promoting Nrf2-mediated antioxidant signaling in asthma mouse model. Life Sci. 218:25–30. 2019. View Article : Google Scholar : PubMed/NCBI

20 

Fu J, Wang Z, Huang L, Zheng S, Wang D, Chen S, Zhang H and Yang S: Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi). Phytother Res. 28:1275–1283. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Qian W, Cai X, Qian Q, Zhang W and Wang D: Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. J Cell Mol Med. 22:4354–4365. 2018. View Article : Google Scholar : PubMed/NCBI

22 

Lu J, Zhong Y, Chen J, Lin X, Lin Z, Wang N and Lin S: Radiation enhances the Epithelial-Mesenchymal transition of A549 cells via miR3591-5p/USP33/PPM1A. Cell Physiol Biochem. 50:721–733. 2018. View Article : Google Scholar : PubMed/NCBI

23 

Barthelemy-Brichant N, Bosquée L, Cataldo D, Corhay JL, Gustin M, Seidel L, Thiry A, Ghaye B, Nizet M, Albert A, et al: Increased IL-6 and TGF-beta1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy. Int J Radiat Oncol Biol Phys. 58:758–767. 2004. View Article : Google Scholar : PubMed/NCBI

24 

Hu HH, Chen DQ, Wang YN, Feng YL, Cao G, Vaziri ND and Zhao YY: New insights into TGF-beta/Smad signaling in tissue fibrosis. Chem Biol Interact. 292:76–83. 2018. View Article : Google Scholar : PubMed/NCBI

25 

Kasai H, Allen JT, Mason RM, Kamimura T and Zhang Z: TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir Res. 6:562005. View Article : Google Scholar : PubMed/NCBI

26 

Xu F, Liu C, Zhou D and Zhang L: TGF-β/Smad Pathway and its regulation in hepatic fibrosis. J Histochem Cytochem. 64:157–167. 2016. View Article : Google Scholar : PubMed/NCBI

27 

Zhu F, Xie N, Jiang Z, Li G, Ma L and Tong T: The cellular Senescence-Inhibited gene is essential for PPM1A Myristoylation to modulate transforming growth factor β signaling. Mol Cell Biol. 38:e00414–18. 2018. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Lu J, Lin S, Lin Z, Lin X, Shen Y and Su J: PPM1A as a key target of the application of <em>Jiawei‑Maxing‑Shigan</em> decoction for the attenuation of radiation‑induced epithelial‑mesenchymal transition in type II alveolar epithelial cells. Mol Med Rep 24: 825, 2021.
APA
Lu, J., Lin, S., Lin, Z., Lin, X., Shen, Y., & Su, J. (2021). PPM1A as a key target of the application of <em>Jiawei‑Maxing‑Shigan</em> decoction for the attenuation of radiation‑induced epithelial‑mesenchymal transition in type II alveolar epithelial cells. Molecular Medicine Reports, 24, 825. https://doi.org/10.3892/mmr.2021.12465
MLA
Lu, J., Lin, S., Lin, Z., Lin, X., Shen, Y., Su, J."PPM1A as a key target of the application of <em>Jiawei‑Maxing‑Shigan</em> decoction for the attenuation of radiation‑induced epithelial‑mesenchymal transition in type II alveolar epithelial cells". Molecular Medicine Reports 24.5 (2021): 825.
Chicago
Lu, J., Lin, S., Lin, Z., Lin, X., Shen, Y., Su, J."PPM1A as a key target of the application of <em>Jiawei‑Maxing‑Shigan</em> decoction for the attenuation of radiation‑induced epithelial‑mesenchymal transition in type II alveolar epithelial cells". Molecular Medicine Reports 24, no. 5 (2021): 825. https://doi.org/10.3892/mmr.2021.12465
Copy and paste a formatted citation
x
Spandidos Publications style
Lu J, Lin S, Lin Z, Lin X, Shen Y and Su J: PPM1A as a key target of the application of <em>Jiawei‑Maxing‑Shigan</em> decoction for the attenuation of radiation‑induced epithelial‑mesenchymal transition in type II alveolar epithelial cells. Mol Med Rep 24: 825, 2021.
APA
Lu, J., Lin, S., Lin, Z., Lin, X., Shen, Y., & Su, J. (2021). PPM1A as a key target of the application of <em>Jiawei‑Maxing‑Shigan</em> decoction for the attenuation of radiation‑induced epithelial‑mesenchymal transition in type II alveolar epithelial cells. Molecular Medicine Reports, 24, 825. https://doi.org/10.3892/mmr.2021.12465
MLA
Lu, J., Lin, S., Lin, Z., Lin, X., Shen, Y., Su, J."PPM1A as a key target of the application of <em>Jiawei‑Maxing‑Shigan</em> decoction for the attenuation of radiation‑induced epithelial‑mesenchymal transition in type II alveolar epithelial cells". Molecular Medicine Reports 24.5 (2021): 825.
Chicago
Lu, J., Lin, S., Lin, Z., Lin, X., Shen, Y., Su, J."PPM1A as a key target of the application of <em>Jiawei‑Maxing‑Shigan</em> decoction for the attenuation of radiation‑induced epithelial‑mesenchymal transition in type II alveolar epithelial cells". Molecular Medicine Reports 24, no. 5 (2021): 825. https://doi.org/10.3892/mmr.2021.12465
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team